Drs. Drucy Borowitz and Manu Jain share new developments in drugs that will treat the underlying cause of cystic fibrosis.
Site Search
Showing 21 - 30 of 140 results
Christina Roman
|
2 min read
Revised Law Includes Designated Funding for Rare Diseases
Press Release
|
April 24, 2008
|
2 min read
News
|
Sept. 26, 2008
|
1 min read
News
|
June 29, 2009
|
1 min read
News
|
July 16, 2009
|
2 min read
News
|
Jan. 20, 2010
|
1 min read
The Cystic Fibrosis Foundation recently signed on to a letter with more than 70 organizations in opposition to the Right to Try Act, which passed in the House of Representatives earlier this month.
News
|
April 5, 2018
|
3 min read
News
|
March 19, 2010
|
1 min read
News
|
Dec. 28, 2007
|
2 min read
The U.S. Food and Drug Administration approved the use of lumacaftor/ivacaftor (Orkambi®) today for children with cystic fibrosis ages 2 to 5 who have two copies of the F508del mutation.
News
|
Aug. 7, 2018
|
3 min read